High levels of CD8+ T cell infiltration—within the tumor core or invasive margin (known as the “Immunoscore”)—have been identified as strong prognostic indicators for recurrence and overall survival in CRC (Mlecnik et al., 2020). This evidence concerns the gene CD8A and neoplasm.